# ![@centessa Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1360315978723254272.png) @centessa Centessa Pharmaceuticals

Centessa Pharmaceuticals posts on X about release, business, ceo, community the most. They currently have [---] followers and [--] posts still getting attention that total [---] engagements in the last [--] hours.

### Engagements: [---] [#](/creator/twitter::1360315978723254272/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1360315978723254272/c:line/m:interactions.svg)

- [--] Year [-----] -8.90%

### Mentions: [--] [#](/creator/twitter::1360315978723254272/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1360315978723254272/c:line/m:posts_active.svg)


### Followers: [---] [#](/creator/twitter::1360315978723254272/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1360315978723254272/c:line/m:followers.svg)

- [--] Year [---] +11%

### CreatorRank: [---------] [#](/creator/twitter::1360315978723254272/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1360315978723254272/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  [travel destinations](/list/travel-destinations)  [financial services](/list/financial-services)  [countries](/list/countries)  [finance](/list/finance) 

**Social topic influence**
[release](/topic/release), [business](/topic/business), [ceo](/topic/ceo), [community](/topic/community), [hosted](/topic/hosted), [financial](/topic/financial), [press release](/topic/press-release), [science](/topic/science), [for the](/topic/for-the), [rio de janeiro](/topic/rio-de-janeiro)

**Top accounts mentioned or mentioned by**
[@jefferies](/creator/undefined) [@guggenheimptnrs](/creator/undefined) [@pipersandler](/creator/undefined) [@evercoreinc](/creator/undefined) [@oppenheimer](/creator/undefined) [@narcolepsynets](/creator/undefined) [@wakenarcolepsys](/creator/undefined) [@emmanuelmignot8](/creator/undefined) [@morganstanley](/creator/undefined) [@saurabhsahamd](/creator/undefined) [@goldmansachs](/creator/undefined) [@guggenheim](/creator/undefined) [@leerinkpartners](/creator/undefined) [@lawdotcomintl](/creator/undefined)

**Top assets mentioned**
[Centessa Pharmaceuticals plc (CNTA)](/topic/$cnta) [Morgan Stanley (MS)](/topic/morgan-stanley) [Goldman Sachs (GS)](/topic/goldman-sachs)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Great weekend spent connecting with individuals living with sleep disorders @ Hypersomnia Foundation's #BeyondSleepySatellitein Atlanta. Photo: CNTA's Deborah Hartman & Suman Machinani with Claire Wylds-Wright & Lindsay Jesteadt Hypersomnia Foundation's CEO & COO respectively"  
[X Link](https://x.com/centessa/status/1848353554915815441)  2024-10-21T13:20Z [---] followers, [---] engagements


"Yesterday Centessa had the privilege of hosting a patient engagement event at our Boston headquarters to raise awareness for #narcolepsy. A big thank you to Matt and Katie for sharing your experiences and insights - your stories are an inspiration to the Centessa team"  
[X Link](https://x.com/centessa/status/1707002838373613739)  2023-09-27T12:02Z [---] followers, [---] engagements


"We are thrilled to share new preclinical data for our first orexin agonist development candidate during an oral presentation at the World Sleep Congress today in Rio de Janeiro Brazil. Read the full press release for more details:"  
[X Link](https://x.com/centessa/status/1717151035058241984)  2023-10-25T12:08Z [---] followers, [----] engagements


"Centessa was proud to sponsor @wakenarcolepsy's Wake Up Narcolepsy National Summit. Members of our team were able to connect with individuals living with #narcolepsy & leading experts including @EmmanuelMignot8 CNTAs SAB Chair who delivered the keynote Waking Up to Orexin"  
[X Link](https://x.com/centessa/status/1786387426941775991)  2024-05-03T13:28Z [---] followers, [---] engagements


"Targeting the orexin pathway represents a potential approach to treating EDS cognitive deficits & fatigue across a range of neurological disorders. With two OX2R agonists in development Centessa is a leader in this emerging drug class. Learn more: https://centessa.com/orexin-agonist-orx750/ https://centessa.com/orexin-agonist-orx750/"  
[X Link](https://x.com/centessa/status/1944738895666528607)  2025-07-14T12:40Z [---] followers, [----] engagements


"This morning $CNTA announced business highlights and financial results for Q2FY25. You can see a brief summary below and find the full release on our website at: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-financial-results-and-7 https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-financial-results-and-7"  
[X Link](https://x.com/centessa/status/1955224661014278451)  2025-08-12T11:07Z [---] followers, [----] engagements


"Next week Centessa management will participate in the @MorganStanley 23rd Annual Global Healthcare Conference. Conference details are in our PR: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-participate-morgan-stanley-23rd-annual https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-participate-morgan-stanley-23rd-annual"  
[X Link](https://x.com/centessa/status/1963198365702733985)  2025-09-03T11:12Z [---] followers, [----] engagements


"Today Centessa presented a poster on the adaptive design of our Phase 2a CRYSTAL-1 study for ORX750. A copy of the poster is available on our website. Visit us at Booth #439 to learn more about our OX2R agonist franchise"  
[X Link](https://x.com/centessa/status/1964997480980107649)  2025-09-08T10:21Z [---] followers, [----] engagements


"This morning CNTA reported Q3FY25 financial results and provided updates on its potential best-in-class orexin receptor [--] (OX2R) agonist program. Highlights from todays release are below and you can find the full release on our website at https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-financial-results-third-0 https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-financial-results-third-0"  
[X Link](https://x.com/anyuser/status/1986041939956048254)  2025-11-05T12:04Z [---] followers, [----] engagements


"CNTA is pleased to announce that Mario Alberto Accardi PhD has been appointed CEO and a member of the Board. See release here: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-ceo-transition-company https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-ceo-transition-company"  
[X Link](https://x.com/anyuser/status/1999088975731143033)  2025-12-11T12:08Z [---] followers, [----] engagements


"We are thrilled to share new data from the ongoing Phase 2a study of our novel investigational drug candidate for the treatment of hemophilia at the 65thASH Annual Meeting. Read the full press release for more details: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-new-data-additional-52-weeks https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-new-data-additional-52-weeks"  
[X Link](https://x.com/centessa/status/1733897295316361477)  2023-12-10T17:11Z [---] followers, [----] engagements


"Our team had a great time at the 65th ASH Annual Meeting this past weekend where we shared new data from the ongoing Phase 2a study of our novel investigational drug candidate for the treatment of hemophilia. Read our recent press release: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-new-data-additional-52-weeks https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-new-data-additional-52-weeks"  
[X Link](https://x.com/centessa/status/1734308390728261962)  2023-12-11T20:25Z [---] followers, [---] engagements


"Our CEO @SaurabhSahaMD will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco CA on Wednesday January [--] at 4:30pm PST. https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-present-42n-annual-jp-morgan-healthcare https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-present-42n-annual-jp-morgan-healthcare"  
[X Link](https://x.com/centessa/status/1734923405814600186)  2023-12-13T13:09Z [---] followers, [---] engagements


"Members of Centessa management will participate in fireside chats at Guggenheims 6th Annual Biotechnology Conference on Wed. February [--] and Leerink Partners Global Biopharma Conference [----] on Mon. March [--]. Read our press release for more details: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-participate-upcoming-investor-6 https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-participate-upcoming-investor-6"  
[X Link](https://x.com/centessa/status/1749418177011052878)  2024-01-22T13:06Z [---] followers, [---] engagements


"Today we announced business highlights and financial results for Q4 and the Full-Year [----]. Read the full press release for more details: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-business-highlights-and https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-business-highlights-and"  
[X Link](https://x.com/centessa/status/1773449159174983809)  2024-03-28T20:36Z [---] followers, [----] engagements


"Today Centessa announced that the FDA has cleared our IND to initiate a Phase [--] first-in-human clinical trial for the treatment of narcolepsy. Read our press release for more information: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-open-ind-orx750-proof-concept https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-open-ind-orx750-proof-concept"  
[X Link](https://x.com/centessa/status/1782365219672441081)  2024-04-22T11:05Z [---] followers, 12.3K engagements


"https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-100-million-proposed-public https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-100-million-proposed-public"  
[X Link](https://x.com/centessa/status/1782868689877958711)  2024-04-23T20:26Z [---] followers, [---] engagements


"Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares. https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-pricing-100-million-public https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-pricing-100-million-public"  
[X Link](https://x.com/centessa/status/1782948446372012337)  2024-04-24T01:43Z [---] followers, [----] engagements


"Today we announced financial results and business highlights for Q1 [----]. Read the full press release for more details: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-financial-results-and-4 https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-financial-results-and-4"  
[X Link](https://x.com/centessa/status/1790113608401068285)  2024-05-13T20:15Z [---] followers, [----] engagements


"https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-participate-upcoming-investor-7 https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-participate-upcoming-investor-7"  
[X Link](https://x.com/centessa/status/1792901757959286936)  2024-05-21T12:54Z [---] followers, [---] engagements


"Today we announced financial results and business highlights for the second quarter of [----]. Read the full press release for more details: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-financial-results-and-5 https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-financial-results-and-5"  
[X Link](https://x.com/centessa/status/1823315150717198728)  2024-08-13T11:06Z [---] followers, [----] engagements


"https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-pricing-upsized-225000000 https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-pricing-upsized-225000000"  
[X Link](https://x.com/centessa/status/1834560207852126670)  2024-09-13T11:50Z [---] followers, [----] engagements


"Today we shared new preclinical data from NHP studies of ORX142 an investigational novel OX2R agonist being advanced for the treatment of EDS in select neurological neurodegenerative and psychiatric disorders at Sleep Europe [----]. Read full release: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-presents-preclinical-data-orx142-novel https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-presents-preclinical-data-orx142-novel"  
[X Link](https://x.com/centessa/status/1839256782322962525)  2024-09-26T10:52Z [---] followers, [----] engagements


"We announced add'l interim data from ongoing Phase [--] study of lead orexin agonist supporting best-in-class potential for NT1 NT2 and IH. We also initiated a Phase 2a study in patients with NT1 NT2 and IH with data expected in [----]. Read release here: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-financial-results-third-quarter https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-financial-results-third-quarter"  
[X Link](https://x.com/centessa/status/1856316621125517726)  2024-11-12T12:42Z [---] followers, [----] engagements


"Centessa is thrilled to welcome Dr. Stephen Kanes as our Chief Medical Officer Full release here: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-appointment-stephen-kanes-md https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-appointment-stephen-kanes-md"  
[X Link](https://x.com/centessa/status/1876964587213348997)  2025-01-08T12:10Z [---] followers, [---] engagements


"https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-poster-presentation-phase-1 https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-poster-presentation-phase-1"  
[X Link](https://x.com/centessa/status/1897761409015939485)  2025-03-06T21:29Z [---] followers, [----] engagements


"Today Centessa announced business highlights and financial results for Q4 and the Full-Year [----]. Read the full release for more details: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-business-highlights-and-0 https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-business-highlights-and-0"  
[X Link](https://x.com/centessa/status/1904127194214871549)  2025-03-24T11:04Z [---] followers, [---] engagements


"In June members of Centessas management team will participate in fireside chats at @Jefferies and @GoldmanSachs. Conference details are in our PR: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-participate-upcoming-investor-10 https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-participate-upcoming-investor-10"  
[X Link](https://x.com/centessa/status/1924436402529272291)  2025-05-19T12:06Z [---] followers, [---] engagements


"Were excited to announce FDA clearance of our IND to initiate a Phase [--] trial of ORX142 the second OX2R agonist in our orexin franchise. The Phase [--] study is expected to begin imminently with clinical data anticipated later this year. Read more: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-clearance-investigational-new https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-clearance-investigational-new"  
[X Link](https://x.com/centessa/status/1934598426248794239)  2025-06-16T13:06Z [---] followers, [----] engagements


"In November and December members of Centessas management team will participate in @GuggenheimPtnrs @Jefferies @PiperSandler @EvercoreInc and @Oppenheimer conferences. Details in our latest press release: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-participate-upcoming-investor-11 https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-participate-upcoming-investor-11"  
[X Link](https://x.com/anyuser/status/1986782404598481360)  2025-11-07T13:06Z [---] followers, [---] engagements


"Today is International Day of Women & Girls in Science. Were proud to celebrate the women of Centessaand across our industrywhose expertise and leadership drive innovation forward"  
[X Link](https://x.com/anyuser/status/2021558126223528217)  2026-02-11T12:13Z [---] followers, [---] engagements


"This February and March Centessas leadership team will participate in upcoming @Guggenheim TD Securities @LeerinkPartners and @Jefferies conferences. Learn more in our latest press https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-participate-upcoming-investor-12 https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-participate-upcoming-investor-12"  
[X Link](https://x.com/anyuser/status/2018671520646574093)  2026-02-03T13:02Z [---] followers, [---] engagements


"Centessa is presenting new preclinical data supporting the potential expansion of OX2R agonists into neuropsychiatric indications at the 64th ACNP Annual Meeting. Check out our poster on our website after the presentation concludes and learn more here: https://investors.centessa.com/events-presentations https://investors.centessa.com/events-presentations"  
[X Link](https://x.com/anyuser/status/2011568633848479864)  2026-01-14T22:38Z [---] followers, [----] engagements


"CNTA is pleased to announce that Mario Alberto Accardi PhD has been appointed CEO and a member of the Board. See release here: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-ceo-transition-company https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-ceo-transition-company"  
[X Link](https://x.com/anyuser/status/1999088975731143033)  2025-12-11T12:08Z [---] followers, [----] engagements


"In November and December members of Centessas management team will participate in @GuggenheimPtnrs @Jefferies @PiperSandler @EvercoreInc and @Oppenheimer conferences. Details in our latest press release: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-participate-upcoming-investor-11 https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-participate-upcoming-investor-11"  
[X Link](https://x.com/anyuser/status/1986782404598481360)  2025-11-07T13:06Z [---] followers, [---] engagements


"This morning CNTA reported Q3FY25 financial results and provided updates on its potential best-in-class orexin receptor [--] (OX2R) agonist program. Highlights from todays release are below and you can find the full release on our website at https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-financial-results-third-0 https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-reports-financial-results-third-0"  
[X Link](https://x.com/anyuser/status/1986041939956048254)  2025-11-05T12:04Z [---] followers, [----] engagements


"Were grateful for the chance to connect with so many in the #narcolepsy community at @NarcolepsyNets Annual Conference this past weekend"  
[X Link](https://x.com/anyuser/status/1982855910461747404)  2025-10-27T17:04Z [---] followers, [---] engagements


"Were headed to Minneapolis for @NarcolepsyNets 38th Annual Conference As proud sponsors were looking forward to a weekend of learning connection & community. Come say hello at our tabletop booth #NarcolepsyAwareness"  
[X Link](https://x.com/anyuser/status/1981783114608226431)  2025-10-24T18:01Z [---] followers, [---] engagements


"What a week 100+ Centessa teammates gathered in Boston to dive into orexin science and connect over our shared mission. Inspired and energized"  
[X Link](https://x.com/anyuser/status/1980969573961617808)  2025-10-22T12:08Z [---] followers, [---] engagements


"Excited to be in Istanbul for European Narcolepsy Days [----] hosted by the European Narcolepsy Network. Proud to support the European Narcolepsy Alliance for Patients and the important work they do"  
[X Link](https://x.com/anyuser/status/1975887643625099665)  2025-10-08T11:34Z [---] followers, [---] engagements


"Congrats to Centessa's legal team for being shortlisted for 'In-House Legal Team of the Year (small teams)' at the [----] British Legal Awards hosted by @lawdotcomINTL. A well-earned honor among a record number of entries & world-class peers"  
[X Link](https://x.com/anyuser/status/1972687760914825264)  2025-09-29T15:39Z [---] followers, [---] engagements


"On #WorldNarcolepsyDay 9/22 we hosted a panel of individuals who discussed their experiences living with narcolepsy. Their stories inspire our work to develop therapies that have the potential to address the real-world needs of many people living with sleep-wake disorders"  
[X Link](https://x.com/anyuser/status/1971187944351465642)  2025-09-25T12:20Z [---] followers, [---] engagements


"Today on #WorldNarcolepsyDay Centessa is proud to stand with patients families and advocates to raise awareness and advance innovation for the [--] million people living with narcolepsy worldwide. Learn more or find ways to show your support here: https://project-sleep.com/world-narcolepsy-day/ https://project-sleep.com/world-narcolepsy-day/"  
[X Link](https://x.com/anyuser/status/1970095318579793987)  2025-09-22T11:58Z [---] followers, [---] engagements


"We hope to see you on Sept [--] at the Wake Up Narcolepsy Bridging Perspectives event As proud sponsors we look forward to connecting with the #narcolepsy community at our tabletop booth"  
[X Link](https://x.com/anyuser/status/1968663317066498069)  2025-09-18T13:08Z [---] followers, [---] engagements


"#WorldNarcolepsyDay is just one week away Join Centessa and the global narcolepsy community in raising awareness of this chronic condition"  
[X Link](https://x.com/anyuser/status/1967598218868666387)  2025-09-15T14:35Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing